Name
|
Transcript ID
|
Alias
|
Description
|
Disease
|
MALAT1
|
ENST00000534336.1
|
HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
pancreatic-cancer
|
HOTAIR
|
NONHSAT028508
|
Gm16258, Hox antisense intergenic RNA, ENSG00000228630
|
Hox antisense intergenic RNA
|
pancreatic-cancer
|
PVT1
|
ENST00000513868.2
|
NCRNA00079, LINC00079, onco-lncRNA-100
|
Pvt1 oncogene (non-protein coding)
|
breast cancer, Burkitt's lymphomas, diabetic nephropathy, Hodgkin's lymphoma, lymphoma, murine plasmacytomas, ovarian cancer, pancreas cancer, prostate cancer,renal cancer
|
LINC-PINT
|
NONHSAT123382
|
FLJ43663, PINT, LincRNA-Pint
|
"long intergenic non-protein coding RNA, p53 induced transcript"
|
pancreatic cancer
|
DAPK1-IT1
|
DAPK1-IT1
|
N/A
|
DAPK1 intronic transcript 1
|
pancreatic cancer
|
LINC00491
|
LINC00491
|
BC008363
|
long intergenic non-protein coding RNA 491
|
pancreatic ductal adenocarcinoma
|
LINC00675
|
LINC00675
|
N/A
|
long intergenic non-protein coding RNA 675
|
pancreatic-cancer
|
DBET
|
NONHSAT099821
|
DBE-T, DUX4L30
|
D4Z4 binding element transcript (non-protein coding)
|
Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy
|
AFAP1-AS1
|
AFAP1-AS1
|
MGC10981
|
AFAP1 antisense RNA 1
|
Barrett's esophagus and esophageal adenocarcinoma, pancreatic-cancer
|
MIR31HG
|
NONHSAT130385
|
LOC554202
|
MIR31 host gene
|
gastric cancer, pancreatic ductal adenocarcinoma
|
LINC01772
|
ENST00000457898.1
|
ENSG00000226029
|
long intergenic non-protein coding RNA 1772
|
alzheimer's disease, ovarian cancer, pancreatic cancer,gastric cancer
|
LINC00226
|
LINC00226
|
C14orf97, NCRNA00226
|
long intergenic non-protein coding RNA 226
|
pancreatic ductal adenocarcinoma
|